发明名称 THERAPEUTIC AGENT ELUTION CONTROL PROCESS
摘要 Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reacti on to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, thes e therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including vulnerable plaque. Implantable coated medical devices may be processed through annealing to better control the elution characteristics of the therapeutic agents. Furthermore, annealing leads to better therapeutic agent stability and a larger device shelf-life.
申请公布号 CA2594906(A1) 申请公布日期 2008.01.26
申请号 CA20072594906 申请日期 2007.07.25
申请人 CORDIS CORPORATION 发明人 KUO, LILY;COOK, DAVID;FALOTICO, ROBERT;ZHAO, JONATHON Z.
分类号 A61L31/16;A61F2/06;A61K31/436;A61L31/10;B05D1/02;B05D1/18 主分类号 A61L31/16
代理机构 代理人
主权项
地址